Study of gene patterns in limb-girdle muscle weakness
Part of Bones, joints & muscles, Genetic & congenital clinical trials.
This study looks at how specific gene changes relate to the pattern of muscle weakness in people with limb-girdle muscular dystrophy (LGMD). It may help doctors better understand the condition and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have genetic test results showing a gene change tied to LGMD
- Your muscle weakness is getting worse over time
- Your weakness mainly affects your shoulder or hip/upper leg area
- Your past testing showed muscle disease changes on an EMG test or a muscle tissue study
- Your genetic testing should not show other gene changes linked to a different muscular dystrophy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune function, muscle appearance, and genetic information in people with limb-girdle muscular dystrophy type 2B. It may help researchers understand the condition better, which can support future treatments.
This study tracks changes in muscle strength and breathing over time in people with certain types of muscular dystrophy. It helps researchers develop better tests to measure how the disease progresses.
This study uses MRI scans to measure muscle changes in people with myotonic dystrophy (DM1 or DM2) and healthy volunteers. The goal is to find better ways to track the disease over time.
This study looks at how genes affect symptoms in children with congenital myopathies or congenital muscular dystrophies. It may help doctors better understand these conditions.
This study uses ultrasound (sound waves) to look at muscles in people with limb-girdle muscular dystrophy. It helps doctors see how the muscles are affected without needing a biopsy.
This study follows people with myotonic dystrophy type 1 over time to learn more about the condition. It is for people of any age who have genetic confirmation of DM1, whether or not they have symptoms.
Hear when a new LGMD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.